CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+

Conditions: B Lymphocytic Leukemia; B Lymphoblastic Lymphoma Interventions: Device: CAR T cell injection Sponsors: Zhu Xiaofan Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials